EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

被引:341
作者
Fang, Wenfeng [1 ,2 ]
Zhang, Jianwei [3 ]
Hong, Shaodong [1 ,2 ]
Zhan, Jianhua [1 ,2 ]
Chen, Nan [4 ]
Qin, Tao [1 ,2 ]
Tang, Yanna [4 ]
Zhang, Yaxiong [1 ,2 ]
Kang, Shiyang [1 ,2 ]
Zhou, Ting [1 ,2 ]
Wu, Xuan [1 ,2 ]
Liang, Wenhua [1 ,2 ]
Hu, Zhihuang [1 ,2 ]
Ma, Yuxiang [1 ,2 ]
Zhao, Yuanyuan [1 ,2 ]
Tian, Ying [1 ,2 ]
Yang, Yunpeng [1 ,2 ]
Xue, Cong [1 ,2 ]
Yan, Yue [1 ,2 ]
Hou, Xue [1 ,2 ]
Huang, Peiyu [1 ,2 ]
Huang, Yan [1 ,2 ]
Zhao, Hongyun [1 ,2 ]
Zhang, Li [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Oncol, Zhuhai, Guangdong, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Nasopharyngeal carcinoma (NPC); latent membrane protein 1 (LMP1); PD-L1; Epstein-Barr virus (EBV); EPSTEIN-BARR-VIRUS; LATENT MEMBRANE PROTEIN-1; HPV-ASSOCIATED HEAD; B7-H1; EXPRESSION; T-LYMPHOCYTES; CANCER; PATHWAY; CELLS; PATHOGENESIS; INFECTION;
D O I
10.18632/oncotarget.2608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PD-L1 expression is a feature of Epstein-Barr virus (EBV) associated malignancies such as nasopharyngeal carcinoma (NPC). Here, we found that EBV-induced latent membrane protein 1 (LMP1) and IFN-gamma pathways cooperate to regulate programmed cell death protein 1 ligand (PD-L1). Expression of PD-L1 was higher in EBV positive NPC cell lines compared with EBV negative cell lines. PD-L1 expression could be increased by exogenous and endogenous induction of LMP1. In agreement, expression of PD-L1 was suppressed by knocking down LMP1 in EBV positive cell lines. We further demonstrated that LMP1 up-regulated PD-L1 through STAT3, AP-1, and NF-kappa B pathways. Besides, IFN-gamma was independent of but synergetic with LMP1 in up-regulating PD-L1 in NPC. Furthermore, we showed that PD-L1 was associated with worse disease-free survival in NPC patients. These results imply that blocking both the LMP1 oncogenic pathway and PD-1/PD-L1 checkpoints may be a promising therapeutic approach for EBV positive NPC patients.
引用
收藏
页码:12189 / 12202
页数:14
相关论文
共 55 条
[1]   Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors [J].
Akbay, Esra A. ;
Koyama, Shohei ;
Carretero, Julian ;
Altabef, Abigail ;
Tchaicha, Jeremy H. ;
Christensen, Camilla L. ;
Mikse, Oliver R. ;
Cherniack, Andrew D. ;
Beauchamp, Ellen M. ;
Pugh, Trevor J. ;
Wilkerson, Matthew D. ;
Fecci, Peter E. ;
Butaney, Mohit ;
Reibel, Jacob B. ;
Soucheray, Margaret ;
Cohoon, Travis J. ;
Janne, Pasi A. ;
Meyerson, Matthew ;
Hayes, D. Neil ;
Shapiro, Geoffrey I. ;
Shimamura, Takeshi ;
Sholl, Lynette M. ;
Rodig, Scott J. ;
Freeman, Gordon J. ;
Hammerman, Peter S. ;
Dranoff, Glenn ;
Wong, Kwok-Kin .
CANCER DISCOVERY, 2013, 3 (12) :1355-1363
[2]   PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer [J].
Badoual, Cecile ;
Hans, Stephane ;
Merillon, Nathalie ;
Van Ryswick, Cordelia ;
Ravel, Patrice ;
Benhamouda, Nadine ;
Levionnois, Emeline ;
Nizard, Mevyn ;
Si-Mohamed, Ali ;
Besnier, Nicolas ;
Gey, Alain ;
Rotem-Yehudar, Rinat ;
Pere, Helene ;
Tran, Thi ;
Guerin, Coralie L. ;
Chauvat, Anne ;
Dransart, Estelle ;
Alanio, Cecile ;
Albert, Sebastien ;
Barry, Beatrix ;
Sandoval, Federico ;
Quintin-Colonna, Francoise ;
Bruneval, Patrick ;
Fridman, Wolf H. ;
Lemoine, Francois M. ;
Oudard, Stephane ;
Johannes, Ludger ;
Olive, Daniel ;
Brasnu, Daniel ;
Tartour, Eric .
CANCER RESEARCH, 2013, 73 (01) :128-138
[3]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465
[4]   X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization [J].
Camp, RL ;
Dolled-Filhart, M ;
Rimm, DL .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7252-7259
[5]   PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies [J].
Chen, Benjamin J. ;
Chapuy, Bjoern ;
Jing Ouyang ;
Sun, Heather H. ;
Roemer, Margaretha G. M. ;
Xu, Mina L. ;
Yu, Hongbo ;
Fletcher, Christopher D. M. ;
Freeman, Gordon J. ;
Shipp, Margaret A. ;
Rodig, Scott J. .
CLINICAL CANCER RESEARCH, 2013, 19 (13) :3462-3473
[6]  
Chen CJ, 2014, RECENT RESULTS CANC, V193, P11, DOI 10.1007/978-3-642-38965-8_2
[7]  
Chen Xiao-Ling, 2009, Ai Zheng, V28, P1328
[8]   Expression of B7-H1 on gastric epithelial cells:: Its potential role in regulating T cells during Helicobacter pylori infection [J].
Das, Soumita ;
Suarez, Giovanni ;
Beswick, Ellen J. ;
Sierra, Johanna C. ;
Graham, David Y. ;
Reyes, Victor E. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (05) :3000-3009
[9]   The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) [J].
Dawson, Christopher W. ;
Port, Rebecca J. ;
Young, Lawrence S. .
SEMINARS IN CANCER BIOLOGY, 2012, 22 (02) :144-153
[10]   PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy [J].
Dolan, Dawn E. ;
Gupta, Shilpa .
CANCER CONTROL, 2014, 21 (03) :231-237